Skip to main content
. Author manuscript; available in PMC: 2020 May 19.
Published in final edited form as: Curr Psychopharmacol. 2020;9(1):7–21.

Table 5.

Global heterozygous prevalence.

SNP Global Heterozygous Prevalence
rs4532 32%
rs1800497 46%
rs 6280 41%
rs1800955 Frequency of C allele =.42*
rs4680 42%
rs1799971 29%
*

Prevalence not available

Note resources used to build Table 5:

CEU-180 samples of Utah residents with Northern and Western European ancestry from the CEPH collection (originally 30 mother-father-child trios); CHB-90 samples of Han Chinese in Beijing, China (previously called HCB, originally 45 unrelated samples); JPT - 91 samples of Japanese in Tokyo, Japan (originally 44 unrelated samples);

YRI-180 samples of Yoruba in Ibadan, Nigeria (originally 30 Yoruba mother-father-child trios); In Phase III of the study, seven additional populations were added to the study;

ASW-90 samples of African ancestry in Southwest USA;

CHD-100 samples of Chinese in Metropolitan Denver, Colorado;

GIH-100 samples of Gujarati Indians in Houston, Texas;

LWK-100 samples of Luhya in Webuye, Kenya;

MEX-90 samples of Mexican ancestry in Los Angeles, California;

MKK-180 samples of Maasai in Kinyawa, Kenya;

TSI-100 samples of Toscani in Italia.